United States· US:0574-7045_7b45a1d7-c3a5-4434-a848-45638cedd6e1
Belladonna and Opium
A medicinal product containing atropa belladonna; opium, registered in United States by Padagis US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ATROPA BELLADONNA; OPIUM
- Manufacturer
- Padagis US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1105747045044 PACKET in 1 BOX (0574-7045-04) / 1 SUPPOSITORY in 1 PACKET
- ndc11057470451212 PACKET in 1 BOX (0574-7045-12) / 1 SUPPOSITORY in 1 PACKET
- ndc110574-7045-04
- ndc110574-7045-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03d2d95a-36b6-495d-9026-682e92a64fe9 GET /v1/drugs/03d2d95a-36b6-495d-9026-682e92a64fe9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RECTAL",
"source": "ndc",
"strength": "16.2; 30",
"substance": "ATROPA BELLADONNA; OPIUM",
"productndc": "0574-7045",
"dosage_form": "SUPPOSITORY",
"dea_schedule": "CII",
"strength_unit": "mg/1; mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about atropa belladonna; opium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.